| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Rupatadine | Rupatadine Dimer Impurity | VL4180001 | View |
| Rupatadine | Rupatadine Inhouse Impurity B | VE006724 | View CAS 156523-04-5 |
Rupatadine Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Rupatadine | Rupatadine Dimer Impurity | VL4180001 | View |
| Rupatadine | Rupatadine Inhouse Impurity B | VE006724 | View CAS 156523-04-5 |
| Catalogue No. | VE006724 |
| CAS No. | 156523-04-5 |
| Molecular Formula | C26H24ClN3O |
| Molecular Weight | 429.95 |
| Parent drug | Rupatadine |
| IUPAC Name | (4-(8-chloro-5, 6-dihydro-11H-benzo[5, 6]cyclohepta[1, 2-b]pyridin-11-ylidene)piperidin-1-yl)(5-methylpyridin-3-yl)methanone |
| Synonyms | N/A |
| References | “Sci-Hub, Determination of Rupatadine in Pharmaceutical Formulations by a Validated Stability-Indicating MEKC Method, 10.1002/Jssc.200800254.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1002/jssc.200800254. |
| Status | In-stock |
| ListName | Rupatadine Inhouse Impurity B |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
